Data

Effect of Accelerated Pacing Rates on Exercise Tolerance, Quality of Life and Arrhythmia Burden in Patients with Evidence of Heart Failure with Preserved Ejection Fraction: The PACE-UP Randomised Controlled Trial

Health Data Australia Contributor Records
Elliott, A/Prof Adrian ; Elliott, Adrian
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58138/VMEP-JC81&rft.title=Effect of Accelerated Pacing Rates on Exercise Tolerance, Quality of Life and Arrhythmia Burden in Patients with Evidence of Heart Failure with Preserved Ejection Fraction: The PACE-UP Randomised Controlled Trial&rft.identifier=http://doi.org/10.58138/VMEP-JC81&rft.publisher=South Australian Health and Medical Research Institute&rft.description=This is a dataset of 160 participants (adults aged 35-75 years old) with pacemakers and early HFpEF from Adelaide, South Australia. Participants will be randomised to an accelerated pacing rate (75bpm) or usual care (60bpm), performing follow-up at 4-weeks and 52-weeks post randomisation. The primary outcome is peak oxygen consumption (VO2peak) assessed by cardiopulmonary exercise testing on an upright cycle ergometer, recorded by a metabolic cart, at baseline and then at 52-weeks post-randomisation.HeSANDA 1.0.0&rft.creator=Elliott, A/Prof Adrian &rft.creator=Elliott, Adrian &rft.date=2029&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12623001187639&rft.coverage=South Australia&rft_subject=FOS: Medical and health sciences&rft.type=dataset&rft.language=English Access data via landing page
Cite Saved to MyRDA Save to MyRDA

Full description

This is a dataset of 160 participants (adults aged 35-75 years old) with pacemakers and early HFpEF from Adelaide, South Australia. Participants will be randomised to an accelerated pacing rate (75bpm) or usual care (60bpm), performing follow-up at 4-weeks and 52-weeks post randomisation. The primary outcome is peak oxygen consumption (VO2peak) assessed by cardiopulmonary exercise testing on an upright cycle ergometer, recorded by a metabolic cart, at baseline and then at 52-weeks post-randomisation.
HeSANDA 1.0.0

Collected:

Data time period: 2024 2028

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

Related Organisations

Related People

Spatial Coverage And Location

text: South Australia

Subjects
FOS: Medical and health sciences |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Heart Foundation

Crossref Funder ID : https://doi.org/10.13039/100002129

Identifiers